pegdinetanib usan planned trade name angiocept investigational anticancer drug acts selective antagonist vascular endothelial growth factor receptor hindering vascularization tumors genetically engineered peptide derivative based monobody technology developed drug entered phase ii clinical trials investigating treatment glioblastoma october august also phase ii trials treatment nonsmall cell lung colorectal pegdinetanib peptide consisting amino acids cysteine number carrying doubly methoxypegylated maleimide derivative molecular mass antineoplastic immunomodulatory drug article stub help wikipedia expanding httpsenwikipediaorgwikipegdinetanib